Work

Figure S12 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer

Year: 2025

Type: other

Abstract: Experiments related to the assessment of the therapeutic potential of R162/MYLK-AS1 ASO in TKI resistance.

DOI: 10.1158/0008-5472.29919060

Authors: Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang

Language: English

Topic: Cancer-related molecular mechanisms research

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4413469687

Cites:

Cited by:

Related to: 10